Back to mobile site

More on HYPR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+35.7% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Hyperfine (NQ:HYPR)
Delayed: 0.78 +0.01 (1.30%)
Prev. Close $0.77  
Open$0.78 
52 Wk High$ 
52 Wk Low$ 
Day High$0.80 
Day Low$0.76 
P/E N/A  
EPS$ 
Volume548,317 

Friends, Peers and Foes (?): AVNS, OFIX, PLSE, S2WA34, SPNC (more...)

Sep 18, 2026 04:08 PM Form 8-K Hyperfine, Inc. For: Sep 17
Sep 15, 2026 08:16 AM Hyperfine completes enrollment in contrast MRI study for Swoop system
Sep 15, 2026 08:15 AM Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
Sep 14, 2026 06:09 AM BTIG Reiterates Buy Rating on Hyperfine Inc. (HYPR)
Aug 26, 2026 08:16 AM Hyperfine reports 3,000 scans and study results in office MRI push
Aug 26, 2026 08:15 AM Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Aug 25, 2026 04:15 PM Form 4 Hyperfine, Inc. For: Aug 24 Filed by: TEISSEYRE THOMAS
Aug 25, 2026 04:15 PM Form 4 Hyperfine, Inc. For: Aug 24 Filed by: HALE BRETT
Aug 20, 2026 09:07 AM BTIG Reiterates Buy Rating on Hyperfine Inc. (HYPR)
Aug 20, 2026 08:15 AM Hyperfine wins FDA clearance for updated portable MRI software
View All Articles

Entities mentioned with HYPR

View All Entities